SLQT
SelectQuote, Inc.
Company overview
- Market capitalization
- $76.03M
- Employees
- 4,269
- Latest publication
- 2026-09-29
About SelectQuote, Inc.
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Services, and Life. It offers medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance-related products, as well as engages in lead generation business; term life, final expense, and other ancillary products; non-commercial auto and home, property, and casualty insurance products. The company also provides SelectRx, a patient-centered pharmacy; Healthcare Select, which uses data from personal health risk and lifestyle assessment; HomeTM (PCPH), an accredited pharmacy; SelectPatient Management (SPM), a platform that helps patients navigate their chronic conditions and manage them using a treatment plan; and individual automobile and homeowners' insurance. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.
Financial statements
Income Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 321,653,000USD | 430,933,000USD | 537,102,000USD | 328,811,000USD | 345,102,000USD | 408,160,000USD | 481,069,000USD | 292,263,000USD |
| Cost Of Revenue | 161,486,000USD | 254,857,000USD | -89,745,000USD | 261,880,000USD | 241,155,000USD | 241,716,000USD | 257,339,000USD | 195,257,000USD |
| Income Tax Expense | 3,712,000USD | 3,927,000USD | 13,663,000USD | -7,204,000USD | -3,493,000USD | 8,579,000USD | -13,680,000USD | 9,526,000USD |
| Net Income | -16,842,000USD | 40,197,000USD | 69,293,000USD | -30,459,000USD | 12,868,000USD | 26,022,000USD | 53,236,000USD | -44,546,000USD |
| Gross Profit | — | 176,076,000USD | 626,847,000USD | 66,931,000USD | 103,947,000USD | 166,444,000USD | 223,730,000USD | 97,006,000USD |
| Research Development | — | 9,777,000USD | 9,595,000USD | 9,911,000USD | 41,591,000USD | 9,967,000USD | 10,044,000USD | 9,074,000USD |
| Selling General Administrative | — | 71,638,000USD | 35,819,000USD | 35,819,000USD | 122,850,000USD | 41,685,000USD | 45,021,000USD | 36,145,000USD |
| Unclassified Operating Expenses | — | 58,100,000USD | 398,935,000USD | — | -47,971,000USD | — | — | — |
| Total Operating Expenses | — | 139,515,000USD | 551,536,000USD | 107,677,000USD | 116,470,000USD | 144,385,000USD | 152,790,000USD | 108,983,000USD |
| Operating Income | — | 36,561,000USD | 75,311,000USD | -40,746,000USD | -12,523,000USD | 22,059,000USD | 70,940,000USD | -11,977,000USD |
| Interest Expense | — | 10,602,000USD | 11,613,000USD | 11,808,000USD | 12,225,000USD | 20,407,000USD | 23,721,000USD | 23,031,000USD |
| Net Interest Income | — | -10,602,000USD | -11,613,000USD | -11,808,000USD | -12,225,000USD | -20,407,000USD | -23,721,000USD | -23,031,000USD |
| Income Before Tax | — | 44,124,000USD | 82,956,000USD | -37,663,000USD | 9,375,000USD | 34,601,000USD | 39,556,000USD | -35,020,000USD |
| Tax Provision | — | 3,927,000USD | 13,662,000USD | -7,204,000USD | -3,493,000USD | 8,579,000USD | -13,680,000USD | 9,526,000USD |
| Net Income From Continuing Ops | — | 40,197,000USD | 69,293,000USD | -30,459,000USD | 12,868,000USD | 26,022,000USD | 53,236,000USD | -44,546,000USD |
| Ebit | — | 36,561,000USD | 93,906,000USD | -25,855,000USD | 21,600,000USD | 55,008,000USD | 63,277,000USD | -11,989,000USD |
| Ebitda | — | 40,946,000USD | 98,228,000USD | -21,555,000USD | 26,476,000USD | 59,933,000USD | 68,337,000USD | -6,390,000USD |
| Depreciation And Amortization | — | 4,385,000USD | 4,322,000USD | 4,300,000USD | 4,876,000USD | 4,925,000USD | 5,060,000USD | 5,599,000USD |
| Reconciled Depreciation | — | 4,385,000USD | 4,322,000USD | 4,300,000USD | 4,876,000USD | 4,925,000USD | 5,060,000USD | 5,599,000USD |
| Total Other Income Expense Net | — | 7,563,000USD | 7,645,000USD | 3,083,000USD | 21,898,000USD | 12,542,000USD | -31,384,000USD | -23,043,000USD |
| Selling And Marketing Expenses | — | — | 107,187,000USD | 61,947,000USD | — | 92,733,000USD | 97,725,000USD | 63,764,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,618,499,000USD | 1,526,594,000USD | 1,321,776,000USD | 1,002,848,000USD | 764,045,000USD | 929,981,000USD | 529,338,000USD | 337,469,000USD |
| Cost Of Revenue | 730,748,000USD | 935,467,000USD | 723,802,000USD | 527,487,000USD | 455,700,000USD | 270,715,000USD | 167,399,000USD | 104,421,000USD |
| Gross Profit | 887,751,000USD | 591,127,000USD | 597,974,000USD | 475,361,000USD | 308,345,000USD | 659,266,000USD | 361,939,000USD | 233,048,000USD |
| Selling General Administrative | 149,022,000USD | 483,947,000USD | 141,042,000USD | 136,518,000USD | 100,945,000USD | 63,114,000USD | 35,283,000USD | 18,169,000USD |
| Selling And Marketing Expenses | 313,687,000USD | — | — | — | 484,084,000USD | 385,291,000USD | 184,157,000USD | 110,265,000USD |
| Total Operating Expenses | 813,827,000USD | 522,628,000USD | 533,424,000USD | 463,778,000USD | 654,354,000USD | 467,028,000USD | 231,787,000USD | 136,760,000USD |
| Operating Income | 73,924,000USD | 68,499,000USD | 64,550,000USD | 11,583,000USD | -346,009,000USD | 192,238,000USD | 130,152,000USD | 96,288,000USD |
| Total Other Income Expense Net | 2,363,000USD | -19,988,000USD | -93,616,000USD | -80,727,000USD | -43,797,000USD | -34,223,000USD | -26,166,000USD | -1,675,000USD |
| Interest Expense | 44,527,000USD | 79,385,000USD | 93,551,000USD | 80,606,000USD | 43,595,000USD | 29,320,000USD | 24,595,000USD | 1,660,000USD |
| Income Before Tax | 76,287,000USD | 48,511,000USD | -29,066,000USD | -69,144,000USD | -389,806,000USD | 158,015,000USD | 103,986,000USD | 94,613,000USD |
| Income Tax Expense | 14,098,000USD | 931,000USD | 5,059,000USD | -10,600,000USD | -92,302,000USD | 33,156,000USD | 24,502,000USD | 22,034,000USD |
| Net Income | 62,189,000USD | 47,580,000USD | -34,125,000USD | -58,544,000USD | -297,504,000USD | 124,859,000USD | 79,484,000USD | 72,579,000USD |
| Net Income Applicable To Common Shares | -11,649,000USD | — | — | -58,544,000USD | -297,504,000USD | 131,046,000USD | -16,004,000USD | 59,918,000USD |
| Research Development | — | 38,681,000USD | 33,524,000USD | 26,015,000USD | 24,729,000USD | 18,623,000USD | 12,347,000USD | 8,326,000USD |
| Net Interest Income | — | -79,385,000USD | -93,551,000USD | -80,606,000USD | -43,595,000USD | -29,320,000USD | -25,761,000USD | -1,660,000USD |
| Tax Provision | — | 931,000USD | 5,059,000USD | -10,600,000USD | -92,302,000USD | 34,803,000USD | 25,016,000USD | 22,034,000USD |
| Net Income From Continuing Ops | — | 47,580,000USD | -34,125,000USD | -58,544,000USD | -297,504,000USD | 131,046,000USD | 81,147,000USD | 72,579,000USD |
| Ebit | — | 127,896,000USD | 64,485,000USD | 11,462,000USD | -346,211,000USD | 187,335,000USD | 128,581,000USD | 96,273,000USD |
| Ebitda | — | 148,356,000USD | 89,483,000USD | 39,343,000USD | -321,487,000USD | 203,477,000USD | 136,574,000USD | 100,975,000USD |
| Depreciation And Amortization | — | 20,460,000USD | 24,998,000USD | 27,881,000USD | 24,724,000USD | 16,142,000USD | 7,993,000USD | 4,702,000USD |
| Reconciled Depreciation | — | 20,460,000USD | 24,998,000USD | 27,881,000USD | 24,724,000USD | 16,142,000USD | 7,993,000USD | 4,702,000USD |
| Unclassified Operating Expenses | — | — | 358,858,000USD | 301,245,000USD | 44,596,000USD | — | — | — |
| Non Operating Income Net Other | — | — | — | — | -202,000USD | -4,903,000USD | — | — |
| Interest Income | — | — | — | — | — | — | — | 1,660,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,286,828,000USD | 1,334,710,000USD | 1,352,259,000USD | 1,206,976,000USD | 1,249,356,000USD | 1,295,833,000USD | 1,279,167,000USD | 1,146,871,000USD |
| Cash And Equivalents | 16,032,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 350,947,000USD | 367,238,000USD | 424,815,000USD | 331,963,000USD | 341,042,000USD | 360,216,000USD | 372,372,000USD | 306,882,000USD |
| Other Current Assets | 24,676,000USD | 20,900,000USD | 21,928,000USD | 23,338,000USD | 25,177,000USD | 19,905,000USD | 19,686,000USD | 20,144,000USD |
| Other Non Current Assets | 2,296,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 636,803,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 192,623,000USD | 231,100,000USD | 234,776,000USD | 215,730,000USD | 212,910,000USD | 193,703,000USD | 194,400,000USD | 166,745,000USD |
| Other Current Liabilities | 8,814,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 24,820,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 351,812,000USD | 663,491,000USD | 619,643,000USD | 546,926,000USD | 575,518,000USD | 557,825,000USD | 326,002,000USD | 269,439,000USD |
| Total Equity Including Noncontrolling Interest | 650,025,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 22,014,000USD | 22,457,000USD | 20,104,000USD | 68,337,000USD | 68,523,000USD | 28,991,000USD | 27,577,000USD | 43,290,000USD |
| Long Term Debt | 348,154,000USD | 353,326,000USD | 385,692,000USD | 324,812,000USD | 316,589,000USD | 362,493,000USD | 684,284,000USD | 637,155,000USD |
| Net Receivables | 166,825,000USD | 311,127,000USD | 380,686,000USD | 297,880,000USD | 283,465,000USD | 260,205,000USD | 340,582,000USD | 276,294,000USD |
| Property Plant Equipment Net | 32,561,000USD | 34,813,000USD | 37,271,000USD | 37,992,000USD | 39,212,000USD | 40,210,000USD | 38,259,000USD | 40,782,000USD |
| Goodwill | 29,438,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 839,000USD | 18,073,000USD | 1,404,000USD | 17,471,000USD | 17,033,000USD | 21,523,000USD | 22,257,000USD | 9,162,000USD |
| Accounts Payable | 74,033,000USD | 103,205,000USD | 80,433,000USD | 34,567,000USD | 59,205,000USD | 77,713,000USD | 87,165,000USD | 51,108,000USD |
| Short Term Debt | 4,448,000USD | 27,122,000USD | 24,991,000USD | 73,223,000USD | 73,343,000USD | 33,838,000USD | 32,558,000USD | 48,054,000USD |
| Common Stock | 1,765,000USD | 1,763,000USD | 1,763,000USD | 1,759,000USD | 1,728,000USD | 1,727,000USD | 1,721,000USD | 1,715,000USD |
| Retained Earnings | -160,000,000USD | -143,158,000USD | -183,355,000USD | -252,648,000USD | -222,189,000USD | -235,057,000USD | -261,079,000USD | -314,315,000USD |
| Total Liab | — | 671,219,000USD | 732,616,000USD | 660,050,000USD | 673,838,000USD | 738,008,000USD | 953,165,000USD | 877,432,000USD |
| Other Current Liab | — | 100,773,000USD | 129,352,000USD | 105,969,000USD | 79,664,000USD | 81,207,000USD | 73,723,000USD | 64,631,000USD |
| Capital Stock | — | 280,520,000USD | 261,744,000USD | 243,615,000USD | 226,102,000USD | 209,340,000USD | 1,721,000USD | 1,715,000USD |
| Good Will | — | 29,438,000USD | 29,438,000USD | 29,438,000USD | 29,438,000USD | 29,438,000USD | 29,438,000USD | 29,438,000USD |
| Cash | — | 35,211,000USD | 22,201,000USD | 10,745,000USD | 32,400,000USD | 80,106,000USD | 12,104,000USD | 10,444,000USD |
| Cash And Short Term Investments | — | 35,211,000USD | 22,201,000USD | 10,745,000USD | 32,400,000USD | 80,106,000USD | 12,104,000USD | 10,444,000USD |
| Net Debt | — | 367,915,000USD | 435,632,000USD | 412,102,000USD | 383,514,000USD | 342,408,000USD | 728,277,000USD | 699,325,000USD |
| Short Long Term Debt Total | — | 403,126,000USD | 457,833,000USD | 422,847,000USD | 415,914,000USD | 422,514,000USD | 740,381,000USD | 709,769,000USD |
| Property Plant Equipment Gross | — | 83,064,000USD | 83,898,000USD | 83,270,000USD | 82,844,000USD | 85,237,000USD | 81,471,000USD | 82,248,000USD |
| Common Stock Shares Outstanding | — | 185,816,000shares | 185,816,000shares | 185,816,000shares | 184,201,000shares | 170,431,000shares | 170,431,000shares | 170,431,000shares |
| Non Current Assets Total | — | 967,472,000USD | 927,444,000USD | 875,013,000USD | 908,314,000USD | 935,617,000USD | 906,795,000USD | 839,989,000USD |
| Non Current Liabilities Total | — | 440,119,000USD | 497,840,000USD | 444,320,000USD | 460,928,000USD | 544,305,000USD | 758,765,000USD | 710,687,000USD |
| Non Current Liabilities Other | — | 18,904,000USD | 46,482,000USD | 65,993,000USD | 80,485,000USD | 115,649,000USD | 19,074,000USD | 2,954,000USD |
| Non Currrent Assets Other | — | 1,410,000USD | 17,455,000USD | 2,440,000USD | 822,631,000USD | 3,262,000USD | 816,841,000USD | 17,583,000USD |
| Net Working Capital | — | 136,138,000USD | 190,039,000USD | 116,233,000USD | 128,132,000USD | 166,513,000USD | 177,972,000USD | 140,137,000USD |
| Unclassified Non Current Assets | — | 883,738,000USD | 841,876,000USD | 787,672,000USD | — | 841,184,000USD | — | 743,024,000USD |
| Unclassified Current Liabilities | — | -22,457,000USD | -20,104,000USD | -68,337,000USD | -68,523,000USD | -28,991,000USD | -27,577,000USD | -43,290,000USD |
| Unclassified Non Current Liabilities | — | 67,889,000USD | 65,666,000USD | 53,515,000USD | 63,854,000USD | 66,163,000USD | 55,407,000USD | 70,578,000USD |
| Unclassified Equity | — | 524,366,000USD | 539,491,000USD | 554,200,000USD | 569,877,000USD | 581,815,000USD | 583,639,000USD | 578,997,000USD |
| Current Deferred Revenue | — | — | — | 1,971,000USD | 698,000USD | 945,000USD | 954,000USD | 2,952,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | 1,327,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,286,828,000USD | 1,249,356,000USD | 1,193,908,000USD | 1,219,251,000USD | 1,290,052,000USD | 1,423,861,000USD | 1,128,044,000USD | 406,940,000USD |
| Cash And Equivalents | 16,032,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 350,947,000USD | 341,042,000USD | 332,923,000USD | 363,224,000USD | 402,773,000USD | 483,424,000USD | 513,833,999USD | 102,957,000USD |
| Other Current Assets | 24,676,000USD | 25,177,000USD | 10,582,000USD | 7,057,000USD | 7,943,000USD | 2,327,000USD | 8,084,999USD | 6,450,000USD |
| Other Non Current Assets | 2,296,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 636,803,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 192,623,000USD | 212,910,000USD | 174,587,000USD | 137,257,000USD | 113,513,000USD | 108,817,000USD | 95,811,000USD | 33,222,000USD |
| Other Current Liabilities | 8,814,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 24,820,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 351,812,000USD | 575,518,000USD | 316,801,000USD | 346,970,000USD | 391,105,000USD | 667,039,000USD | 545,689,000USD | 263,252,000USD |
| Total Equity Including Noncontrolling Interest | 650,025,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 22,014,000USD | 68,523,000USD | 45,854,000USD | 33,883,000USD | 7,169,000USD | 2,360,000USD | — | 3,920,000USD |
| Long Term Debt | 348,154,000USD | 316,589,000USD | 637,480,000USD | 664,625,000USD | 698,423,000USD | 459,043,000USD | 311,814,000USD | 21,647,000USD |
| Net Receivables | 166,825,000USD | 283,465,000USD | 270,893,000USD | 267,444,000USD | 248,079,000USD | 194,467,000USD | 136,879,000USD | 95,937,000USD |
| Property Plant Equipment Net | 32,561,000USD | 39,212,000USD | 42,410,000USD | 51,015,000USD | 69,820,000USD | 60,924,000USD | 22,150,000USD | 13,759,000USD |
| Goodwill | 29,438,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 839,000USD | 17,033,000USD | 24,172,000USD | 24,940,000USD | 47,556,000USD | 53,281,000USD | 28,072,000USD | 4,895,000USD |
| Accounts Payable | 74,033,000USD | 59,205,000USD | 36,587,000USD | 27,577,000USD | 24,766,000USD | 34,079,000USD | 22,891,000USD | 7,634,000USD |
| Short Term Debt | 4,448,000USD | 73,343,000USD | 50,693,000USD | 39,185,000USD | 12,566,000USD | 7,837,000USD | 49,000USD | 3,953,000USD |
| Common Stock | 1,765,000USD | 1,728,000USD | 1,694,000USD | 1,669,000USD | 1,644,000USD | 1,635,000USD | 1,622,000USD | 1,153,000USD |
| Retained Earnings | -160,000,000USD | -222,189,000USD | -269,769,000USD | -235,644,000USD | -177,100,000USD | 120,404,000USD | -2,792,000USD | 200,446,000USD |
| Total Liab | — | 673,838,000USD | 877,107,000USD | 872,281,000USD | 898,947,000USD | 756,822,000USD | 582,355,000USD | 143,688,000USD |
| Other Current Liab | — | 79,664,000USD | 74,588,000USD | 67,662,000USD | 68,152,000USD | 61,821,000USD | 71,133,000USD | 19,610,000USD |
| Capital Stock | — | 226,102,000USD | 1,694,000USD | 1,669,000USD | 1,644,000USD | 1,635,000USD | 1,622,000USD | 1,950,000USD |
| Good Will | — | 29,438,000USD | 29,438,000USD | 29,136,000USD | 29,136,000USD | 68,019,000USD | 46,577,000USD | 5,364,000USD |
| Cash | — | 32,400,000USD | 42,690,000USD | 83,156,000USD | 140,997,000USD | 286,454,000USD | 368,870,000USD | 570,000USD |
| Cash And Short Term Investments | — | 32,400,000USD | 42,690,000USD | 83,156,000USD | 140,997,000USD | 286,454,000USD | 368,870,000USD | 570,000USD |
| Current Deferred Revenue | — | 698,000USD | 12,719,000USD | 2,833,000USD | 8,029,000USD | 5,080,000USD | 1,738,000USD | 2,025,000USD |
| Net Debt | — | 383,514,000USD | 671,234,000USD | 648,644,000USD | 604,067,000USD | 218,845,000USD | -56,948,000USD | 25,109,000USD |
| Short Long Term Debt Total | — | 415,914,000USD | 713,924,000USD | 731,800,000USD | 745,064,000USD | 505,299,000USD | 311,922,000USD | 25,679,000USD |
| Property Plant Equipment Gross | — | 82,844,000USD | 81,807,000USD | 51,015,000USD | 69,820,000USD | 60,924,000USD | 22,150,000USD | 13,759,000USD |
| Common Stock Shares Outstanding | — | 181,895,000shares | 168,519,000shares | 166,140,000shares | 164,042,000shares | 165,544,000shares | 162,190,730shares | 162,190,730shares |
| Non Current Assets Total | — | 908,314,000USD | 860,985,000USD | 856,027,000USD | 887,279,000USD | 940,437,000USD | 614,210,000USD | 303,983,000USD |
| Non Current Liabilities Total | — | 460,928,000USD | 702,520,000USD | 735,024,000USD | 785,434,000USD | 648,005,000USD | 486,544,000USD | 110,466,000USD |
| Non Current Liabilities Other | — | 80,485,000USD | 1,811,000USD | 2,926,000USD | 33,946,000USD | 7,384,000USD | 14,635,000USD | — |
| Non Currrent Assets Other | — | 2,547,000USD | 40,997,000USD | 750,936,000USD | 740,767,000USD | 758,213,000USD | 1,408,000USD | 279,965,000USD |
| Net Working Capital | — | 128,132,000USD | 158,336,000USD | 225,967,000USD | 289,260,000USD | 384,618,000USD | 418,023,000USD | 69,735,000USD |
| Unclassified Non Current Assets | — | 820,084,000USD | 723,968,000USD | -733,075,000USD | -725,548,000USD | -758,213,000USD | 52,843,000USD | -279,747,000USD |
| Unclassified Current Liabilities | — | -68,523,000USD | -45,854,000USD | -33,883,000USD | -7,169,000USD | -2,360,000USD | — | -3,920,000USD |
| Unclassified Non Current Liabilities | — | 63,854,000USD | 63,229,000USD | 25,064,000USD | -49,951,000USD | 27,674,000USD | 38,575,000USD | — |
| Unclassified Equity | — | 569,877,000USD | 579,070,000USD | 565,597,000USD | 553,201,000USD | 543,136,000USD | 546,491,000USD | 146,204,000USD |
| Short Term Investments | — | — | 5,027,000USD | — | — | — | — | — |
| Inventory | — | — | 8,758,000USD | 5,567,000USD | 5,754,000USD | 176,000USD | 47,805,000USD | — |
| Accumulated Other Comprehensive Income | — | — | 4,112,000USD | 13,679,000USD | 11,716,000USD | 229,000USD | -1,254,000USD | -9,226,000USD |
| Unclassified Current Assets | — | — | -5,027,000USD | — | — | — | -47,805,000USD | — |
| Other Liab | — | — | — | 42,409,000USD | 52,936,000USD | 152,704,000USD | 120,420,000USD | 88,740,000USD |
| Other Assets | — | — | — | 733,075,000USD | 725,548,000USD | 758,213,000USD | 463,160,000USD | 279,747,000USD |
| Net Tangible Assets | — | — | — | 292,894,000USD | 314,413,000USD | 553,589,000USD | 471,040,000USD | 251,978,000USD |
| Deferred Long Term Liab | — | — | — | — | 50,080,000USD | 1,200,000USD | 1,100,000USD | — |
| Treasury Stock | — | — | — | — | — | — | — | -77,275,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -16,842,000USD | 40,197,000USD | 69,293,000USD | -30,459,000USD | 12,868,000USD | 26,022,000USD | 53,236,000USD | -44,546,000USD |
| Depreciation | 4,482,000USD | 4,385,000USD | 4,322,000USD | 4,300,000USD | 4,876,000USD | 4,925,000USD | 5,060,000USD | 5,599,000USD |
| Stock Based Compensation | 3,382,000USD | 3,678,000USD | 3,475,000USD | 4,327,000USD | 4,852,000USD | 4,960,000USD | 4,699,000USD | 3,846,000USD |
| Capital Expenditures | -1,183,000USD | -947,000USD | 1,838,000USD | -3,984,000USD | -501,000USD | -949,000USD | -2,272,000USD | -2,574,000USD |
| Investing Cash Flow | -4,562,000USD | — | — | — | — | — | — | — |
| Change In Cash | -14,579,000USD | 13,010,000USD | 7,639,000USD | -21,367,000USD | -49,156,000USD | 72,589,000USD | 3,189,000USD | -32,246,000USD |
| End Cash Flow | 21,677,000USD | — | — | — | — | — | — | — |
| Other Non Cash Items | — | -20,876,000USD | -18,363,000USD | -12,831,000USD | -26,739,000USD | -26,851,000USD | 18,669,000USD | 7,324,000USD |
| Change To Account Receivables | — | 27,604,000USD | -137,110,000USD | 17,901,000USD | -2,253,000USD | 52,657,000USD | -137,504,000USD | 12,035,000USD |
| Change In Working Capital | — | 22,291,000USD | -72,063,000USD | 22,208,000USD | -30,763,000USD | 53,486,000USD | -96,678,000USD | 1,641,000USD |
| Total Cash From Operating Activities | — | 49,117,000USD | 52,000USD | -21,623,000USD | -37,482,000USD | 71,120,000USD | -28,694,000USD | -16,610,000USD |
| Free Cash Flow | — | 48,170,000USD | 1,890,000USD | -25,607,000USD | -37,983,000USD | 70,171,000USD | -30,966,000USD | -19,184,000USD |
| Total Cashflows From Investing Activities | — | -3,952,000USD | -3,647,000USD | -3,984,000USD | -3,111,000USD | -3,357,000USD | -2,272,000USD | -2,574,000USD |
| Net Borrowings | — | -32,219,000USD | 11,285,000USD | 6,772,000USD | -8,536,000USD | -324,968,000USD | 35,995,000USD | -8,501,000USD |
| Total Cash From Financing Activities | — | -32,247,000USD | 11,234,000USD | 4,240,000USD | -8,563,000USD | 4,826,000USD | 34,155,000USD | -13,062,000USD |
| Begin Period Cash Flow | — | 22,201,000USD | 15,699,000USD | 37,066,000USD | 86,222,000USD | 13,633,000USD | 10,444,000USD | 42,690,000USD |
| End Period Cash Flow | — | 35,211,000USD | 23,338,000USD | 15,699,000USD | 37,066,000USD | 86,222,000USD | 13,633,000USD | 10,444,000USD |
| Other Cashflows From Financing Activities | — | -28,000USD | 2,290,000USD | -72,000USD | -13,000USD | -1,059,000USD | -1,840,000USD | -4,561,000USD |
| Unclassified Investing Cash Flow | — | -3,005,000USD | -2,926,000USD | 6,910,000USD | 3,111,000USD | 3,357,000USD | 4,245,000USD | 4,706,000USD |
| Sale Purchase Of Stock | — | — | 2,460,000USD | -2,460,000USD | — | — | — | -3,915,000USD |
| Other Cashflows From Investing Activities | — | — | -2,559,000USD | -2,926,000USD | -2,610,000USD | -2,408,000USD | -1,973,000USD | -2,132,000USD |
| Unclassified Operating Cash Flow | — | — | 13,388,000USD | -9,168,000USD | -2,576,000USD | 8,578,000USD | -13,680,000USD | 9,526,000USD |
| Unclassified Financing Cash Flow | — | — | -4,801,000USD | — | — | 330,853,000USD | — | 3,915,000USD |
| Investments | — | — | — | -3,984,000USD | -3,111,000USD | -3,357,000USD | -2,272,000USD | -2,574,000USD |
| Issuance Of Capital Stock | — | — | — | — | 0USD | — | — | — |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 17,489,000USD | 20,460,000USD | 24,998,000USD | 27,881,000USD | 24,724,000USD | 16,142,000USD | 7,993,000USD | 4,702,000USD |
| Stock Based Compensation | 14,862,000USD | 18,357,000USD | 13,816,000USD | 11,310,000USD | 7,052,000USD | 5,165,000USD | 9,498,000USD | 86,000USD |
| Deferred Income Tax | 11,876,000USD | — | — | — | — | — | — | — |
| Other Non Cash Items | -8,659,000USD | -5,050,000USD | 28,897,000USD | 43,672,000USD | 58,729,000USD | 11,911,000USD | 3,238,000USD | 344,000USD |
| Change To Account Receivables | -15,437,000USD | -75,065,000USD | -35,616,000USD | -26,689,000USD | -18,478,000USD | -352,929,000USD | -15,585,000USD | -8,676,000USD |
| Change To Liabilities | 21,894,000USD | — | — | -3,649,000USD | -4,063,000USD | 19,728,000USD | 15,672,000USD | 2,810,000USD |
| Change In Working Capital | 3,997,000USD | -72,314,000USD | -19,513,000USD | -32,520,000USD | -38,599,000USD | -306,526,000USD | -188,659,000USD | -99,589,000USD |
| Operating Cash Flow | 31,885,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -4,276,000USD | -2,191,000USD | -11,666,000USD | -9,125,000USD | -34,649,000USD | -22,988,000USD | -15,552,000USD | -8,636,000USD |
| Other Investing Activities | 0USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -11,870,000USD | 11,314,000USD | 19,697,000USD | 16,803,000USD | 2,924,000USD | 31,069,000USD | 15,549,000USD | 13,351,000USD |
| Investing Cash Flow | -16,146,000USD | — | — | — | — | — | — | — |
| Net Debt Issuance | -527,000USD | — | — | — | — | — | — | — |
| Net Common Stock Issuance | -2,545,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -28,056,000USD | -6,978,000USD | — | 1,187,000USD | — | 24,519,000USD | -180,864,000USD | — |
| Financing Cash Flow | -31,128,000USD | — | — | — | — | — | — | — |
| Change In Cash | -15,389,000USD | -5,624,000USD | -40,466,000USD | -57,841,000USD | -145,457,000USD | -82,416,000USD | 368,300,000USD | -388,000USD |
| End Cash Flow | 21,677,000USD | — | — | — | — | — | — | — |
| Net Income | — | 25,032,000USD | -34,125,000USD | -58,544,000USD | -297,504,000USD | 124,859,000USD | 81,147,000USD | 72,579,000USD |
| Total Cash From Operating Activities | — | -11,666,000USD | 15,236,000USD | -19,377,000USD | -338,314,000USD | -115,442,000USD | -61,776,000USD | 113,000USD |
| Free Cash Flow | — | -13,857,000USD | 3,570,000USD | -28,502,000USD | -372,963,000USD | -138,430,000USD | -77,328,000USD | -8,523,000USD |
| Investments | — | -11,314,000USD | -14,846,000USD | -9,125,000USD | -1,000,000USD | -64,016,000USD | -51,370,000USD | -8,636,000USD |
| Total Cashflows From Investing Activities | — | -11,314,000USD | -14,846,000USD | -9,125,000USD | -42,576,000USD | -64,016,000USD | -51,370,000USD | -8,636,000USD |
| Net Borrowings | — | -306,010,000USD | -39,032,000USD | -17,991,000USD | 237,903,000USD | 144,384,000USD | 290,596,000USD | 6,085,000USD |
| Total Cash From Financing Activities | — | 17,356,000USD | -40,856,000USD | -29,339,000USD | 235,433,000USD | 97,042,000USD | 481,446,000USD | 8,135,000USD |
| Issuance Of Capital Stock | — | 337,855,000USD | 0USD | 0USD | 0USD | 0USD | 475,200,000USD | 0USD |
| Begin Period Cash Flow | — | 42,690,000USD | 83,156,000USD | 140,997,000USD | 286,454,000USD | 368,870,000USD | 570,000USD | 958,000USD |
| End Period Cash Flow | — | 37,066,000USD | 42,690,000USD | 83,156,000USD | 140,997,000USD | 286,454,000USD | 368,870,000USD | 570,000USD |
| Other Cashflows From Investing Activities | — | -9,123,000USD | -8,031,000USD | -7,678,000USD | -9,851,000USD | -8,081,000USD | 3,000USD | -4,715,000USD |
| Other Cashflows From Financing Activities | — | -7,511,000USD | -1,824,000USD | -11,348,000USD | -2,798,000USD | -47,342,000USD | -14,856,000USD | 4,042,000USD |
| Unclassified Operating Cash Flow | — | 1,849,000USD | 1,163,000USD | -11,176,000USD | -92,716,000USD | 33,007,000USD | 25,007,000USD | 21,991,000USD |
| Sale Purchase Of Stock | — | — | -374,000USD | -40,000USD | -148,000USD | -10,362,000USD | 661,570,000USD | -34,000USD |
| Dividends Paid | — | — | — | -1,147,000USD | -148,000USD | -14,157,000USD | -275,000,000USD | -1,958,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -145,457,000USD | -82,416,000USD | — | — |
| Change To Inventory | — | — | — | — | — | -19,728,000USD | -15,672,000USD | -2,810,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2026Quarterly · 2026-03-31 | Product | Pharmacy | 195,270,000 | USD | 0001794783-26-000030 |
| Q3 2026Quarterly · 2026-03-31 | Product | Product And Service Other | -761,000 | USD | 0001794783-26-000030 |
| Q3 2026Quarterly · 2026-03-31 | Product | Services | 235,663,000 | USD | 0001794783-26-000030 |
| Q2 2026Quarterly · 2025-12-31 | Product | Pharmacy | 227,209,000 | USD | 0001794783-26-000012 |
| Q2 2026Quarterly · 2025-12-31 | Product | Product And Service Other | 1,445,000 | USD | 0001794783-26-000012 |
| Q2 2026Quarterly · 2025-12-31 | Product | Services | 309,893,000 | USD | 0001794783-26-000012 |
| Q1 2026Quarterly · 2025-09-30 | Product | Pharmacy | 218,544,000 | USD | 0001794783-25-000096 |
| Q1 2026Quarterly · 2025-09-30 | Product | Product And Service Other | 1,178,000 | USD | 0001794783-25-000096 |
| Q1 2026Quarterly · 2025-09-30 | Product | Services | 110,267,000 | USD | 0001794783-25-000096 |
| Q4 2025Quarterly · 2025-06-30 | Product | Pharmacy | 210,599,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Product And Service Other | 2,310,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Services | 134,503,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-06-30 | Product | Pharmacy | 728,753,000 | USD | 0001794783-25-000081 |
| FY 2025Yearly · 2025-06-30 | Product | Product And Service Other | 4,169,000 | USD | 0001794783-25-000081 |
| FY 2025Yearly · 2025-06-30 | Product | Services | 797,841,000 | USD | 0001794783-25-000081 |
| Q3 2025Quarterly · 2025-03-31 | Product | Pharmacy | 185,271,000 | USD | 0001794783-26-000030 |
| Q3 2025Quarterly · 2025-03-31 | Product | Product And Service Other | 0 | USD | 0001794783-26-000030 |
| Q3 2025Quarterly · 2025-03-31 | Product | Services | 222,889,000 | USD | 0001794783-26-000030 |
| Q2 2025Quarterly · 2024-12-31 | Product | Pharmacy | 180,000,000 | USD | 0001794783-26-000012 |
| Q2 2025Quarterly · 2024-12-31 | Product | Product And Service Other | 861,000 | USD | 0001794783-26-000012 |
| Q2 2025Quarterly · 2024-12-31 | Product | Services | 301,069,000 | USD | 0001794783-26-000012 |
| Q1 2025Quarterly · 2024-09-30 | Product | Pharmacy | 152,883,000 | USD | 0001794783-25-000096 |
| Q1 2025Quarterly · 2024-09-30 | Product | Product And Service Other | 998,000 | USD | 0001794783-25-000096 |
| Q1 2025Quarterly · 2024-09-30 | Product | Services | 139,380,000 | USD | 0001794783-25-000096 |
| Q4 2024Quarterly · 2024-06-30 | Product | Pharmacy | 140,988,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Product And Service Other | 1,197,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Services | 166,220,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-06-30 | Product | Pharmacy | 464,853,000 | USD | 0001794783-25-000081 |
| FY 2024Yearly · 2024-06-30 | Product | Product And Service Other | 4,172,000 | USD | 0001794783-25-000081 |
| FY 2024Yearly · 2024-06-30 | Product | Services | 856,923,000 | USD | 0001794783-25-000081 |
| FY 2024Yearly · 2024-06-30 | Segment | Auto Home | 36,227,000 | USD | 0001794783-24-000061 |
| FY 2024Yearly · 2024-06-30 | Segment | Healthcare Services | 478,491,000 | USD | 0001794783-24-000061 |
| FY 2024Yearly · 2024-06-30 | Segment | Life | 157,826,000 | USD | 0001794783-24-000061 |
| FY 2024Yearly · 2024-06-30 | Segment | Senior | 649,232,000 | USD | 0001794783-24-000061 |
| Q4 2024Quarterly · 2024-06-30 | Segment | Auto Home | 7,579,000 | USD | 0001794783-24-000061 |
| Q4 2024Quarterly · 2024-06-30 | Segment | Healthcare Services | 145,206,000 | USD | 0001794783-24-000061 |
| Q4 2024Quarterly · 2024-06-30 | Segment | Life | 41,970,000 | USD | 0001794783-24-000061 |
| Q4 2024Quarterly · 2024-06-30 | Segment | Senior | 107,526,000 | USD | 0001794783-24-000061 |
| Q3 2024Quarterly · 2024-03-31 | Segment | Auto Home | 9,134,000 | USD | 0001794783-24-000026 |
| Q3 2024Quarterly · 2024-03-31 | Segment | Healthcare Services | 124,207,000 | USD | 0001794783-24-000026 |
| Q3 2024Quarterly · 2024-03-31 | Segment | Life | 40,686,000 | USD | 0001794783-24-000026 |
| Q3 2024Quarterly · 2024-03-31 | Segment | Senior | 204,259,000 | USD | 0001794783-24-000026 |
| Q2 2024Quarterly · 2023-12-31 | Segment | Auto Home | 10,487,000 | USD | 0001794783-24-000013 |
| Q2 2024Quarterly · 2023-12-31 | Segment | Healthcare Services | 111,710,000 | USD | 0001794783-24-000013 |
| Q2 2024Quarterly · 2023-12-31 | Segment | Life | 37,367,000 | USD | 0001794783-24-000013 |
| Q2 2024Quarterly · 2023-12-31 | Segment | Senior | 247,529,000 | USD | 0001794783-24-000013 |
| Q1 2024Quarterly · 2023-09-30 | Segment | Auto Home | 9,027,000 | USD | 0001794783-23-000142 |
| Q1 2024Quarterly · 2023-09-30 | Segment | Healthcare Services | 97,368,000 | USD | 0001794783-23-000142 |
| Q1 2024Quarterly · 2023-09-30 | Segment | Life | 37,803,000 | USD | 0001794783-23-000142 |
| Q1 2024Quarterly · 2023-09-30 | Segment | Senior | 89,918,000 | USD | 0001794783-23-000142 |
| FY 2023Yearly · 2023-06-30 | Product | Pharmacy | 239,547,000 | USD | 0001794783-25-000081 |
| FY 2023Yearly · 2023-06-30 | Product | Product And Service Other | 4,256,000 | USD | 0001794783-25-000081 |
| FY 2023Yearly · 2023-06-30 | Product | Services | 763,301,000 | USD | 0001794783-25-000081 |
| FY 2023Yearly · 2023-06-30 | Segment | Auto Home | 21,862,000 | USD | 0001794783-24-000061 |
| FY 2023Yearly · 2023-06-30 | Segment | Healthcare Services | 252,075,000 | USD | 0001794783-24-000061 |
| FY 2023Yearly · 2023-06-30 | Segment | Life | 145,640,000 | USD | 0001794783-24-000061 |
| FY 2023Yearly · 2023-06-30 | Segment | Senior | 583,271,000 | USD | 0001794783-24-000061 |
| Q3 2023Quarterly · 2023-03-31 | Segment | Auto Home | 8,238,000 | USD | 0001794783-24-000026 |
| Q3 2023Quarterly · 2023-03-31 | Segment | Healthcare Services | 70,725,000 | USD | 0001794783-24-000026 |
| Q3 2023Quarterly · 2023-03-31 | Segment | Life | 36,950,000 | USD | 0001794783-24-000026 |
| Q3 2023Quarterly · 2023-03-31 | Segment | Senior | 185,200,000 | USD | 0001794783-24-000026 |
| Q2 2023Quarterly · 2022-12-31 | Segment | Auto Home | 7,808,000 | USD | 0001794783-24-000013 |
| Q2 2023Quarterly · 2022-12-31 | Segment | Healthcare Services | 55,480,000 | USD | 0001794783-24-000013 |
| Q2 2023Quarterly · 2022-12-31 | Segment | Life | 33,995,000 | USD | 0001794783-24-000013 |
| Q2 2023Quarterly · 2022-12-31 | Segment | Senior | 223,826,000 | USD | 0001794783-24-000013 |
| FY 2022Yearly · 2022-06-30 | Product | Pharmacy | 59,460,000 | USD | 0001794783-24-000061 |
| FY 2022Yearly · 2022-06-30 | Product | Product And Service Other | 6,560,000 | USD | 0001794783-24-000061 |
| FY 2022Yearly · 2022-06-30 | Product | Services | 704,585,000 | USD | 0001794783-24-000061 |
| FY 2022Yearly · 2022-06-30 | Segment | Auto Home | 27,877,000 | USD | 0001794783-24-000061 |
| FY 2022Yearly · 2022-06-30 | Segment | Healthcare Services | 70,035,000 | USD | 0001794783-24-000061 |
| FY 2022Yearly · 2022-06-30 | Segment | Life | 151,704,000 | USD | 0001794783-24-000061 |
| FY 2022Yearly · 2022-06-30 | Segment | Senior | 514,429,000 | USD | 0001794783-24-000061 |
| Q2 2022Quarterly · 2021-12-31 | Segment | Auto Home | 6,135,000 | USD | 0001794783-22-000013 |
| Q2 2022Quarterly · 2021-12-31 | Segment | Life | 32,780,000 | USD | 0001794783-22-000013 |
| Q2 2022Quarterly · 2021-12-31 | Segment | Senior | 157,967,000 | USD | 0001794783-22-000013 |
| Q1 2022Quarterly · 2021-09-30 | Segment | Auto Home | 7,469,000 | USD | 0001794783-22-000088 |
| Q1 2022Quarterly · 2021-09-30 | Segment | Healthcare Services | 5,983,000 | USD | 0001794783-22-000088 |
| Q1 2022Quarterly · 2021-09-30 | Segment | Life | 45,982,000 | USD | 0001794783-22-000088 |
| Q1 2022Quarterly · 2021-09-30 | Segment | Senior | 100,604,000 | USD | 0001794783-22-000088 |
| FY 2021Yearly · 2021-06-30 | Product | Pharmacy | 1,791,000 | USD | 0001794783-23-000099 |
| FY 2021Yearly · 2021-06-30 | Product | Product And Service Other | 109,418,000 | USD | 0001794783-23-000099 |
| FY 2021Yearly · 2021-06-30 | Product | Services | 818,772,000 | USD | 0001794783-23-000099 |
| FY 2021Yearly · 2021-06-30 | Segment | Auto Home | 30,913,000 | USD | 0001794783-23-000099 |
| FY 2021Yearly · 2021-06-30 | Segment | Healthcare Services | 3,890,000 | USD | 0001794783-23-000099 |
| FY 2021Yearly · 2021-06-30 | Segment | Life | 177,669,000 | USD | 0001794783-23-000099 |
| FY 2021Yearly · 2021-06-30 | Segment | Senior | 724,811,000 | USD | 0001794783-23-000099 |
| FY 2020Yearly · 2020-06-30 | Product | Product | 50,308,000 | USD | 0001794783-22-000067 |
| FY 2020Yearly · 2020-06-30 | Product | Product And Service Other | 4,601,000 | USD | 0001794783-22-000067 |
| FY 2020Yearly · 2020-06-30 | Product | Services | 474,429,000 | USD | 0001794783-22-000067 |
| FY 2020Yearly · 2020-06-30 | Segment | Auto Home | 41,189,000 | USD | 0001794783-22-000067 |
| FY 2020Yearly · 2020-06-30 | Segment | Life | 127,790,000 | USD | 0001794783-22-000067 |
| FY 2020Yearly · 2020-06-30 | Segment | Other | 863,000 | USD | 0001794783-22-000067 |
| FY 2020Yearly · 2020-06-30 | Segment | Senior | 361,673,000 | USD | 0001794783-22-000067 |
| FY 2019Yearly · 2019-06-30 | Product | Product And Service Other | 41,469,000 | USD | 0001794783-21-000122 |
| FY 2019Yearly · 2019-06-30 | Product | Services | 296,000,000 | USD | 0001794783-21-000122 |
| FY 2019Yearly · 2019-06-30 | Segment | Auto Home | 35,054,000 | USD | 0001794783-21-000122 |
| FY 2019Yearly · 2019-06-30 | Segment | Life | 110,493,000 | USD | 0001794783-21-000122 |
| FY 2019Yearly · 2019-06-30 | Segment | Senior | 192,257,000 | USD | 0001794783-21-000122 |
| FY 2018Yearly · 2018-06-30 | Product | Product And Service Other | 27,077,000 | USD | 0001794783-20-000014 |
| FY 2018Yearly · 2018-06-30 | Product | Services | 206,611,000 | USD | 0001794783-20-000014 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.